University of Leeds
Leeds, United Kingdom
Paul Emery is Versus Arthritis Professor of Rheumatology, University of Leeds/ Leeds NIHR Biomedical Research Centre at Leeds Teaching Hospitals Trust, UK
He was President of EULAR 2009-2011, European Society for Rheumatology. Served on editorial boards of major rheumatology journals. Inaugurated President of ISEMIR (International extremity MRI society). NIHR Senior Investigator since 2008. Recipient of Roche Biennial Award for Clinical Rheumatology; Rheumatology Hospital Doctor of the Year; EULAR prize 2002 for outstanding contribution to rheumatology research, awarded the Carol Nachman Prize, . In 2018 was awarded an OBE
His research interests centre around the immunopathogenesis and immunotherapy of rheumatoid arthritis, SpA, psoriatic and connective tissue diseases. Has a special interest in the factors leading to persistent inflammation, instrumental in bringing sensitive imaging (MRI/US) into rheumatology practice. Established the concept of early intervention in inflammatory arthritis with a model for early arthritis now adopted throughout the world. Currently focusing on the prevention of autoimmune diseases with national programmes identifying patients in the pre-clinical phase. This prevention strategy is applied not only to inflammatory arthritis but systemic lupus erythematosus, Sjorgens syndrome, scleroderma and psoriatic disease. Has published >1200 peer-reviewed articles, h factor >180
Tuesday, November 14, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis: Consultant (Ongoing)
Tuesday, November 14, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis: Consultant (Ongoing)
Wednesday, November 15, 2023
8:25 AM – 8:50 AM PT
Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis: Consultant (Ongoing)